Manu Rangachari
Chercheur universitaire
Axe Neurosciences
Publications
View all-
article Rangachari M, Ghasemlou N
Chemokines as targets to treat chronic postoperative pain
Pain 167 (5), 2026.
-
article Anderson AC, Rangachari M
Loss-of-function mutations ensure that response to immune checkpoint therapy is NOD2 be denied
Sci Immunol 10 (111), 2025.
-
article Zeydan B, Neyal N, Nathoo N, Rangachari M, Atkinson EJ, Son J, Conway BL, Tobin WO, Keegan BM, Weinshenker BG, Kantarci K, Oh J, Kantarci OH
Effects of androgen modifying therapies on disease activity in older men with multiple sclerosis
J Neuroimmunol 403 2025.
Projects
- endMS National Education and Training Program: Summer School and SPRINT, from 2023-06-15 to 2026-06-14
- Stressed to a T: The role of stress granule dynamics in regulating effector T cell function, from 2023-04-01 to 2028-03-31
- The interplay of sex hormones and chromosomes dictates pathogenicity in progressive CNS autoimmunity, from 2024-04-01 to 2029-03-31
- Oxidative phosphorylation drives B cell and Tph cell inflammatory responses within the CNS, from 2025-04-01 to 2028-03-31
- Oxidative phosphorylation drives neuroinflammatory B cell and Tph cell responses in progressive CNS autoimmunity, from 2025-04-01 to 2028-03-31
- Into the (re-) wild: moving beyond lab-raised mice in order to make EAE more reflective of human MS, from 2026-04-01 to 2028-03-31
- Sins of the father: a parent of origin effect to explain pathogenic outcomes in progressive MS, from 2024-04-01 to 2025-03-31